President Trump Vows to Win Drug War, Does Not Mention Marijuana

President Trump Vows to Win Drug War, Does Not Mention Marijuana

President Trump Vows to Win Drug War, Does Not Mention Marijuana

$SLTK, $GWPH,

  • Southern California company, Solis Tech, Inc (OTCMKT:SLTK), focused on the efficient indoor growing of Medical Marijuana
  •  The next big brain cancer drug may come from Medical Marijuana

In his address to Congress Tuesday night, President Trump echoed Ronald Reagan, as he vowed to defeat illegal drug use in the US.

The Silver Lining, his “War” directed at heroin, cocaine and other hard drugs. Marijuana was not said once in his speech.

“Our terrible drug epidemic will slow down and ultimately, stop,” he promised as part of his “Make America Great Again”accomplishments to come. “Dying industries will come roaring back to life. Heroic veterans will get the care they so desperately need…”

And, having forgotten, or more likely, never learned, the lessons of the past 70 years + of American drug prohibition, he is going to defeat drugs the old-fashioned way, with more War on Drugs.

“To protect our citizens, I have directed the Department of Justice to form a Task Force on Reducing Violent Crime,” Trump said. “I have further ordered the Departments of Homeland Security and Justice, along with the Department of State and the Director of National Intelligence, to coordinate an aggressive strategy to dismantle the criminal cartels that have spread across our Nation.”

Drug law enforcement costs money.

The DEA and other federal agencies are already waging a multi-billion dollar a year War on Drugs.

So, if President Trump’s budget proposals match his rhetoric, he will have to be prepared to spend billions more.

President Trump can ratchet up the drug war in some ways without relying on congressional appropriations through his control of the executive branch.

For instance, his Justice Department (DOJ) could direct federal prosecutors to seek mandatory minimum prison sentences in most or all drug cases. That, too, has budgetary consequences, but not until some time down the road.

President Trump addressed drug use as a public health issue, saying he would “expand treatment for those who have become so badly addicted.”

President Trump’s Tuesday night anti-crime and drug talk was interwoven with talk about the border, comingling immigration, drugs, and his border wall in politically powerful rhetoric.

“We’ve defended the borders of other nations, while leaving our own borders wide open, for anyone to cross — and for drugs to pour in at a now unprecedented rate,” he said, ignoring the quadrupling in size of the Border Patrol in the past 20 years and the billions pumped into border security since 2001. “We will stop the drugs from pouring into our country and poisoning our youth.”

President Trump also said that he was already making America safer with his immigration enforcement actions.

“As we speak, we are removing gang members, drug dealers and criminals that threaten our communities and prey on our citizens. Bad ones are going out as I speak tonight and as I have promised,” he said.

President Trump’s drug war rhetoric is pure Triumpism. The proof will be in budget proposals and Justice Department directives, but in terms of progressive recreational drug policy, the tone is ominous tone.

So far Eleven US Senators Urge Trump Admistriation Not to Mess With Legal Marijuana. The 11 Senators, led by Lisa Murkowski (R-AL) and Elizabeth Warren (D-MA) sent a letter to US Attorney General Jeff Sessions Thursday urging him to uphold the current federal policy of letting states implement their own Marijuana laws. “We respectfully request that you uphold DOJ’s existing policy regarding states that have implemented strong and effective regulations for recreational use,” they wrote. “It is critical that states continue to implement these laws.”

I believe that any move against Marijuana would be politically problematic, economically foolish, and directly opposes to some of The Trump Administration’s other highlighted goals, such as fighting Mexican drug cartels and creating American jobs here in America. Not to mention the huge potential of state and federal tax revenue.

It is worthy to note: that the next big brain cancer drug may come from Marijuana.

GW Pharmaceuticals (NASDAQ:GWPH) is already well on its way to winning the 1st ever US approval for a cannabis-derived therapy. But an early trial suggests that these treatments could also be an effective way to fight one of most devastating forms of brain cancers: glioblastoma multiforme.

The UK-based company unveiled preliminary data recently from a mid-stage study on an experimental drug combining cannabidiol and THC, the “high” producing element of marijuana. Results so far show that the drug boosted brain cancer patients’ median survival rates by about six months compared to a placebo. Typically, this type of cancer ravages the brain and (on average) leaves 70% of patients dead within 2 years of being diagnosed.

*Southern California company focused on the efficient indoor growing of Medical Marijuana

Solis Tek Inc. (OTCMKT:SLTK) focuses on the research, design, development, and manufacturing of advanced and energy efficient indoor horticulture lighting and ancillary equipment in the United States and internationally. It offers digital ballasts; metal halide, and mercury vapor and high-pressure sodium lamps; light emitting diode lighting products that produces less heat; and reflectors in various sizes for use with its digital ballasts and lamps. The company markets its products directly; and through distributors to hydroponic retailers,  direct contacts, social media, and industry trade shows. Solis Tek Inc. is based in Carson, California.

Symbol Last Trade Date Change Open High Low Volume
OTCMKT:SLTK 1.10 3 March 2017 0.03 1.08 1.1 1.04 62,600
HeffX-LTN Analysis for SLTK: Overall Short Intermediate Long
Bullish (0.37) Bullish (0.25) Very Bullish (0.58) Bullish (0.28)
Symbol Last Trade Date Change Open High Low Volume
NASDAQ:GWPH 131.35 3 March 2017 1.51 130.37 136.95 129.85 588,100
HeffX-LTN Analysis for GWPH: Overall Short Intermediate Long
Bullish (0.36) Bullish (0.36) Bullish (0.33) Bullish (0.39)

Have a terrific weekend.

 

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

You must be logged in to post comments :  
CONNECT WITH